Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Study confirms intensive treatment of diabetic patients significantly reduces heart disease

20.06.2005


Yet another proven benefit of tight glucose control for those with type 1 diabetes



New study results confirm, for the first time, that intensive treatment of diabetic patients results in a significantly lower risk of heart disease. In fact, it can cut the risk of cardiovascular disease nearly in half. Researchers say this is yet another proven benefit of the long-term effects of tight glucose control in patients with type 1 diabetes.

The new finding was announced on Sunday at the annual scientific meeting of the American Diabetes Association. The results stem from studying cardiovascular events in patients who took part in the Diabetes Control and Complications Trial (DCCT) and a follow-up NIH study. The original DCCT results reported in 1993 showed a 50-60 percent reduction in eye, kidney, and nerve disease. Now researchers also know this treatment helps reduce severe cardiovascular events.


"This is exciting news for those coping with diabetes. This intensive treatment of glucose control could allow them to live longer with less suffering," said Stanley Schwartz, MD, the principal investigator on the DCCT follow-up study, called the Epidemiology of Diabetes Interventions and Complications (EDIC). Schwartz is also the Director of Diabetes Disease Management for the University of Pennsylvania Health System. "The EDIC study examined the long-term effects of an average of 6.5 years of conventional insulin treatment versus intensive insulin treatment."

Schwartz adds that before, with conventional treatments, the patient would receive 1-2 shots of insulin a day and occasional office visits and standard dietary reminders. In intensive treatment, patients are given 3-4 shots of insulin a day, frequent dietary reminders, monthly doctor’s appointments, and psychological support.

In results announced last Sunday, the ADA says among the more than 1,300 volunteers continuing to participate in the DCCT/EDIC study (which is a remarkable 93% of the original volunteer base), the intensively treated patients had a 57% reduction in the number of serious cardiovascular events such as heart attacks and strokes -- compared to the conventionally treated group.

According to the ADA, the risk of heart disease is about 10 times higher in people with type 1 diabetes than in people without diabetes. About 18.2 million people in the United States have diabetes, the most common cause of blindness, kidney failure, and amputations in adults and a major cause of heart disease and stroke.

Susanne Hartman | EurekAlert!
Further information:
http://www.uphs.upenn.edu

More articles from Studies and Analyses:

nachricht Rutgers-led innovation could spur faster, cheaper, nano-based manufacturing
14.02.2018 | Rutgers University

nachricht New study from the University of Halle: How climate change alters plant growth
12.01.2018 | Martin-Luther-Universität Halle-Wittenberg

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: In best circles: First integrated circuit from self-assembled polymer

For the first time, a team of researchers at the Max-Planck Institute (MPI) for Polymer Research in Mainz, Germany, has succeeded in making an integrated circuit (IC) from just a monolayer of a semiconducting polymer via a bottom-up, self-assembly approach.

In the self-assembly process, the semiconducting polymer arranges itself into an ordered monolayer in a transistor. The transistors are binary switches used...

Im Focus: Demonstration of a single molecule piezoelectric effect

Breakthrough provides a new concept of the design of molecular motors, sensors and electricity generators at nanoscale

Researchers from the Institute of Organic Chemistry and Biochemistry of the CAS (IOCB Prague), Institute of Physics of the CAS (IP CAS) and Palacký University...

Im Focus: Hybrid optics bring color imaging using ultrathin metalenses into focus

For photographers and scientists, lenses are lifesavers. They reflect and refract light, making possible the imaging systems that drive discovery through the microscope and preserve history through cameras.

But today's glass-based lenses are bulky and resist miniaturization. Next-generation technologies, such as ultrathin cameras or tiny microscopes, require...

Im Focus: Stem cell divisions in the adult brain seen for the first time

Scientists from the University of Zurich have succeeded for the first time in tracking individual stem cells and their neuronal progeny over months within the intact adult brain. This study sheds light on how new neurons are produced throughout life.

The generation of new nerve cells was once thought to taper off at the end of embryonic development. However, recent research has shown that the adult brain...

Im Focus: Interference as a new method for cooling quantum devices

Theoretical physicists propose to use negative interference to control heat flow in quantum devices. Study published in Physical Review Letters

Quantum computer parts are sensitive and need to be cooled to very low temperatures. Their tiny size makes them particularly susceptible to a temperature...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

2nd International Conference on High Temperature Shape Memory Alloys (HTSMAs)

15.02.2018 | Event News

Aachen DC Grid Summit 2018

13.02.2018 | Event News

How Global Climate Policy Can Learn from the Energy Transition

12.02.2018 | Event News

 
Latest News

Researchers invent tiny, light-powered wires to modulate brain's electrical signals

21.02.2018 | Life Sciences

The “Holy Grail” of peptide chemistry: Making peptide active agents available orally

21.02.2018 | Life Sciences

Atomic structure of ultrasound material not what anyone expected

21.02.2018 | Materials Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>